|
Keyword Index |
2022, Volume 38, Number 2 |
Keywords | Page numbers |
Adenoid ameloblastoma |
168 |
Alveolar adenoma |
158 |
Atrophic kidney-like lesion |
148 |
Bone marrow biopsy |
99 |
Breast |
153 |
Breast cancer |
114 |
Cartilage |
153 |
Castleman disease |
142 |
Clinicopathological characteristics |
106 |
Cyclin D1 |
83 |
Differential diagnosis |
158 |
Diffuse glioma |
90 |
EBV |
142 |
Emerging renal tumors |
162 |
GLUT-1 |
114 |
Germinotropic lymphoproliferative disorder |
142 |
Granuloma |
122, 133 |
HHV-8 |
142 |
Hepatocellular carcinoma |
133 |
Immunohistochemistry |
158, 162, 114, 83 |
Immunotherapy |
106 |
Inflammation |
133 |
Kidney |
148 |
Low-grade oncocytic tumor |
162 |
Lung tumour |
158 |
Male breast |
153 |
Medullary thyroid carcinoma |
106 |
Metastasis |
99 |
Neuroblastoma |
99 |
Odontogenic cysts |
168 |
Odontogenic tumors |
168 |
Oncocytic renal tumors |
162 |
Papilloma |
153 |
Pathology |
122 |
Pediatric pathology |
83 |
Pleomorphic adenoma |
153 |
Primary glioblastoma |
90 |
Programmed death-ligand 1 (PD-L1) |
106 |
Promoter mutation |
90 |
Renal |
122 |
Renal biopsy |
122 |
Renal tumors |
83 |
Surgical ciliated cyst |
168 |
Survival |
90 |
TERT p |
90 |
Thyroid-like follicular carcinoma |
148 |
Tumor differentiation |
99 |
Tumor percentage |
99 |
WHO classification |
168 |
Wilms tumor |
83 |
|
|
|